Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Aquaculture Vaccines Market Size, Share & Trends Analysis Report by Product (Attenuated Live Vaccines, Inactivated Vaccines), Route of Administration, Application, Distribution Channel and Region with Growth Forecasts, 2025-2033" has been added to ResearchAndMarkets.com's offering.
The global aquaculture vaccines market, valued at USD 212.3 million in 2024, is anticipated to surge to USD 396.1 million by 2033, marking a CAGR of 7.01% from 2025 to 2033. Key drivers include rising disease incidence within aquaculture systems, government and regulatory support, and technological strides in vaccine development.
The increasing disease outbreaks in aquaculture, particularly in China, India, and Vietnam, contribute significantly to market growth. Such outbreaks account for over 30% of production losses in these regions and globally cause nearly 50% of aquaculture losses, with developing nations suffering the most. The sector's acceleration, along with intensified fish farming and international trade, heightens pathogen exposure, provoking viral, bacterial, and parasitic infections. Consequently, farmers are turning towards vaccines to mitigate these risks, secure consistent production, and decrease reliance on antibiotics. Cost-effective and preventive, aquaculture vaccines improve fish health, welfare, and sustainability, essential for productive operations across diverse species worldwide.
Governments globally are enacting policies favoring sustainable aquaculture practices and imposing rigid biosecurity measures. Initiatives like Canada's investment of over USD 3.5 million in clean technology projects enhance sector sustainability and competitiveness. Similarly, India's Marine & Aquaculture Biotechnology program promotes vaccine development and the discovery of marine bioactive compounds for new therapies. Regulatory endorsements, such as USDA approvals, EU GMP certifications, and India's emerging vaccine guidelines, assure quality and market acceptance, fostering innovation and guaranteeing more standardization across the global aquaculture field.
Technological advancements in biotechnology, such as recombinant DNA applications, yeast expression platforms, and multivalent vaccines, contribute to creating highly effective, environmentally benign vaccines tailored to species-specific needs. These innovations enhance vaccine efficacy, reduce disease transmission, and elevate production yields, with streamlined vaccine administration through oral or immersion methods facilitating mass vaccination efforts. Notably, UVAXX's 2024 launch of an epitope-based vaccine against Scale Drop Disease Virus in barramundi exemplifies how advanced immunotechnology can mitigate severe aquaculture losses in Southeast Asia. Such evolving technologies spur market diversification and application expansion.
Global Aquaculture Vaccine Market Report Segmentation This comprehensive report projects revenue growth across global, regional, and national levels, analyzing industry trends in each sub-segment from 2021 to 2033. The report segments the market based on product, application, administration route, distribution channel, and region.
Product Outlook (Revenue, USD Million, 2021-2033)
- Attenuated Live Vaccines
- Inactivated Vaccines
- Other Vaccines
Route of Administration Outlook (Revenue, USD Million, 2021-2033)
- Oral
- Injected
- Immersion & Spray
Application Outlook (Revenue, USD Million, 2021-2033)
- Bacterial
- Viral
- Parasitic
Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Retail
- E-Commerce
- Hospital/Clinic Pharmacy
Region Outlook (Revenue, USD Million, 2021-2033)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value (USD) in 2024 | $212.3 Million |
| Forecasted Market Value (USD) by 2033 | $396.1 Million |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
Companies Featured
The key companies profiled in this Aquaculture Vaccines market report include:
- Zoetis
- Phibro Animal Health Corporation
- Elanco
- Merck & Co., Inc.
- KBNP
- CAVAC
- Kyoto Biken Laboratories, Inc.
- Nisseiken Co., Ltd.
- Vaxxinova International BV
- HIPRA
For more information about this report visit https://www.researchandmarkets.com/r/ylw92k
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
